253 related articles for article (PubMed ID: 16701103)
21. Effects of esmolol on patients with left ventricular dysfunction.
Iskandrian AS; Bemis CE; Hakki AH; Panidis I; Heo J; Toole JG; Hua TA; Allin D; Kane-Marsch S
J Am Coll Cardiol; 1986 Jul; 8(1):225-31. PubMed ID: 2872244
[TBL] [Abstract][Full Text] [Related]
22. Acute beta-blockade prevents myocardial beta-adrenergic receptor desensitization and preserves early ventricular function after brain death.
Pandalai PK; McLean KM; Bulcao CF; Duffy JY; D'Souza KM; Merrill WH; Pearl JM; Akhter SA
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):792-8. PubMed ID: 18374758
[TBL] [Abstract][Full Text] [Related]
23. [Esmolol in anesthesiology: pharmacology and indications].
Fita G; Gomar C; Rovira I
Rev Esp Anestesiol Reanim; 1999 Nov; 46(9):404-14. PubMed ID: 10613078
[TBL] [Abstract][Full Text] [Related]
24. Acute hemodynamic effects of beta-blockers in patients with severe congestive heart failure: comparison of celiprolol and esmolol.
Felix SB; Stangl V; Kieback A; Doerffel W; Staudt A; Wernecke KD; Baumann G; Stangl K
J Cardiovasc Pharmacol; 2001 Nov; 38(5):666-71. PubMed ID: 11602813
[TBL] [Abstract][Full Text] [Related]
25. Beta-blocker use in severe sepsis and septic shock: a systematic review.
Sanfilippo F; Santonocito C; Morelli A; Foex P
Curr Med Res Opin; 2015; 31(10):1817-25. PubMed ID: 26121122
[TBL] [Abstract][Full Text] [Related]
26. The use of esmolol and magnesium to prevent haemodynamic responses to extubation after coronary artery grafting.
Arar C; Colak A; Alagol A; Uzer SS; Ege T; Turan N; Duran E; Pamukcu Z
Eur J Anaesthesiol; 2007 Oct; 24(10):826-31. PubMed ID: 17583595
[TBL] [Abstract][Full Text] [Related]
27. Effects of low doses of esmolol on cardiac and vascular function in experimental septic shock.
Wei C; Louis H; Schmitt M; Albuisson E; Orlowski S; Levy B; Kimmoun A
Crit Care; 2016 Dec; 20(1):407. PubMed ID: 27998289
[TBL] [Abstract][Full Text] [Related]
28. [Effects on the hemodynamics and myocardial contractility of 2 beta blockader agents: propranolol and proctolol].
Sanguinetti M; Picchio FM; Maresta A; Branzi A; Baccarani G; Binetti G
G Ital Cardiol; 1972; 2(5):710-9. PubMed ID: 4404053
[No Abstract] [Full Text] [Related]
29. Efficacy and Safety of Esmolol in Treatment of Patients with Septic Shock.
Du W; Wang XT; Long Y; Liu DW
Chin Med J (Engl); 2016 Jul; 129(14):1658-65. PubMed ID: 27411452
[TBL] [Abstract][Full Text] [Related]
30. Infusion of the beta-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats.
Suzuki T; Morisaki H; Serita R; Yamamoto M; Kotake Y; Ishizaka A; Takeda J
Crit Care Med; 2005 Oct; 33(10):2294-301. PubMed ID: 16215384
[TBL] [Abstract][Full Text] [Related]
31. Different pharmacological properties of two enantiomers in a unique beta-blocker, nebivolol.
Ignarro LJ
Cardiovasc Ther; 2008; 26(2):115-34. PubMed ID: 18485134
[TBL] [Abstract][Full Text] [Related]
32. Circulatory responses of the dog to acute isovolumic anaemia in the presence of high-grade adrenergic beta-receptor blockade.
Clarke TN; Foëx P; Roberts JG; Saner CA; Bennett MJ
Br J Anaesth; 1980 Mar; 52(3):337-41. PubMed ID: 7370150
[TBL] [Abstract][Full Text] [Related]
33. The use of esmolol in whole-body hyperthermia: cardiovascular effects.
Berry JM; Michalsen A; Nagle V; Bull JM
Int J Hyperthermia; 1997; 13(3):261-8. PubMed ID: 9222810
[TBL] [Abstract][Full Text] [Related]
34. β
Hoiland RL; Ainslie PN; Bain AR; MacLeod DB; Stembridge M; Drvis I; Madden D; Barak O; MacLeod DM; Dujic Z
J Appl Physiol (1985); 2017 Apr; 122(4):899-906. PubMed ID: 27125844
[TBL] [Abstract][Full Text] [Related]
35. beta-Adrenergic blockade during systemic inflammation: impact on cellular immune functions and survival in a murine model of sepsis.
Schmitz D; Wilsenack K; Lendemanns S; Schedlowski M; Oberbeck R
Resuscitation; 2007 Feb; 72(2):286-94. PubMed ID: 17118511
[TBL] [Abstract][Full Text] [Related]
36. Beta-receptor blockade, physical activity, and metabolism.
Lohmann FW; Loesment WA; Kaehler H
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S45-52. PubMed ID: 11527136
[TBL] [Abstract][Full Text] [Related]
37. [Hemodynamic effects of dipyridamole (Persantin) following beta-blockade in coronary failure].
Kinsbergen M; Friedemann M
Schweiz Med Wochenschr; 1973 Feb; 103(8):312-5. PubMed ID: 4144418
[No Abstract] [Full Text] [Related]
38. Effects of selective β1-adrenoceptor blockade on cardiovascular and renal function and circulating cytokines in ovine hyperdynamic sepsis.
Calzavacca P; Lankadeva YR; Bailey SR; Bailey M; Bellomo R; May CN
Crit Care; 2014 Nov; 18(6):610. PubMed ID: 25413250
[TBL] [Abstract][Full Text] [Related]
39. [Effect of esmolol on cardiovascular responses induced by scopolamine butylbromide].
Suzuki S; Nonaka A; Abe F
Masui; 2005 Nov; 54(11):1277-81. PubMed ID: 16296368
[TBL] [Abstract][Full Text] [Related]
40. Pilot study to assess the influence of beta-blockade on mitral regurgitant volume and left ventricular work in degenerative mitral valve disease.
Stewart RA; Raffel OC; Kerr AJ; Gabriel R; Zeng I; Young AA; Cowan BR
Circulation; 2008 Sep; 118(10):1041-6. PubMed ID: 18725484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
